![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 1999, Cold Spring Harbor Laboratory Press Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo 1Department of Anatomy and Program in Developmental Biology, and 2Department of Pediatrics, School of Medicine, University of California at San Francisco, San Francisco, California 94143-0452 USA 3Corresponding author. Received April 21, 1999; Accepted June 4, 1999. This article has been cited by other articles in PMC.Abstract Fgf8 and Fgf4 encode FGF family members that are coexpressed in the primitive streak of the gastrulating mouse embryo. We have analyzed the phenotype of Fgf8−/− embryos and discovered that they fail to express Fgf4 in the streak. In the absence of both FGF8 and FGF4, epiblast cells move into the streak and undergo an epithelial-to-mesenchymal transition, but most cells then fail to move away from the streak. As a consequence, no embryonic mesoderm- or endoderm-derived tissues develop, although extraembryonic tissues form. Patterning of the prospective neuroectoderm is greatly perturbed in the mutant embryos. Anterior neuroectoderm markers are widely expressed, at least in part because the anterior visceral endoderm, which provides signals that regulate their expression, is not displaced proximally in the absence of definitive endoderm. Posterior neuroectoderm markers are not expressed, presumably because there is neither mesendoderm underlying the prospective neuroectoderm nor a morphologically normal node to provide the inductive signals necessary for their expression. This study identifies Fgf8 as a gene essential for gastrulation and shows that signaling via FGF8 and/or FGF4 is required for cell migration away from the primitive streak. Keywords: anterior visceral endoderm, cell migration, epithelial-to-mesenchymal transition, Fgf4, Fgf8, gastrulation, mouse embryo, neuroectoderm patterning, primitive streak Gastrulation is the process by which a single layer of epithelial cells is transformed into the three germ layers of the embryo—endoderm, mesoderm, and ectoderm—and the basic body plan is established. In the mouse, the undifferentiated epithelium that will develop into the embryo proper is a cup-shaped sheet known as the epiblast. Gastrulation begins at ~6.5 days after fertilization [embryonic day (E) 6.5], when cells on opposite sides of the epiblast start to move toward a common region, known as the primitive streak. Its location is defined as the posterior side of the embryo, and anterior is on the opposite side of the epiblast. As cells move into the streak region they undergo an epithelial-to-mesenchymal transition (EMT) and subsequently move away from the streak. The streak is therefore a region through which cells are continually trafficking. The proximal–distal (P-D) axis of the embryo runs from the rim of the cup-like epiblast to its base (see Fig. Fig.1F).1
An understanding of mouse gastrulation requires identifying molecules involved in stimulating the movement of epiblast cells towards the streak, inducing them to undergo the EMT, stimulating them to move away from the streak, and determining their fate after they leave the streak. Several lines of evidence suggest that fibroblast growth factors (FGFs) may regulate one or more of these processes. This was first suggested by experiments showing that treatment of Xenopus animal cap explants with FGF2 induced cells that would otherwise adopt an ectodermal fate to form mesoderm (Kimelman and Kirschner 1987; Slack et al. 1987). Subsequent studies have suggested that FGF signaling has multiple functions during gastrulation in Xenopus, including induction of mesoderm, regulation of cell movement, and control of anterior–posterior (A-P) patterning (for review, see Slack et al. 1996). The strongest evidence that FGF signaling is essential for gastrulation in mice comes from loss-of-function studies of FGF receptor 1 (Fgfr1), one of four known vertebrate FGFR genes. Embryos homozygous for null alleles of Fgfr1 fail to gastrulate normally (Deng et al. 1995; Yamaguchi et al. 1995). On the basis of studies of chimeras formed by aggregating Fgfr1−/− cells with wild-type morulae, it was suggested that the primary defect caused by loss of Fgfr1 function is a deficiency in the ability of cells to make the transition from an epithelial to a mesenchymal morphology and thus to traverse the streak (Ciruna et al. 1997). To date, 18 different vertebrate FGF genes have been identified (Ohbayashi et al. 1998 and references therein). Gene expression analyses have shown that five of these genes, Fgf3 (Wilkinson et al. 1988), Fgf4 (Niswander and Martin 1992), Fgf5 (Haub and Goldfarb 1991; Hébert et al. 1991), Fgf8 (Crossley and Martin 1995; Mahmood et al. 1995), and Fgf17 (Maruoka et al. 1998), are expressed in prestreak- and streak-stage embryos. Fgf3 (Mansour et al. 1993), Fgf5 (Hébert et al. 1994), and Fgf17 (J. Xu and D. Ornitz, pers. comm.) are not individually required for gastrulation, as null mutant homozygotes are viable and fertile. Fgf4 is expressed in the primitive streak, but it has not been possible to determine whether it is required for gastrulation, because Fgf4−/− embryos die shortly after implantation, 2 days before streak formation begins (Feldman et al. 1995). Fgf8 is expressed just prior to streak formation in a patch of epiblast cells on the proximal prospective posterior side of the embryo, as well as in the visceral endoderm (VE), a layer of extraembryonic cells that envelops the epiblast before and during the streak stages of development. Subsequently, its expression is localized to cells within the primitive streak and is down-regulated shortly after they exit it (Crossley and Martin 1995; Mahmood et al. 1995; Maruoka et al. 1998). We described previously the production of mice carrying an allelic series of mutations at the Fgf8 locus (Meyers et al. 1998). Two of the mutant alleles, Fgf8Δ2,3 and Fgf8Δ2,3n, are presumed to be null alleles because they lack exons 2 and 3, which encode most of the ~120-amino-acid core domain that is conserved in all FGF family members. Sequences within this conserved domain confer an ability to bind to heparin and to signal-transducing FGFRs (for review, see Basilico and Moscatelli 1992). Mice heterozygous for Fgf8Δ2,3n or Fgf8Δ2,3 are viable and fertile, but embryos homozygous for either allele apparently lack all embryonic mesoderm- and endoderm-derived structures and do not survive beyond E9.5. In this study our goal was to determine what aspect of gastrulation is affected in Fgf8 null mutant homozygotes. Results Failure of cell migration away from the primitive streak in Fgf8 mutant homozygotes Embryos identified by PCR analysis as either Fgf8Δ2,3 or Fgf8Δ2,3n homozygotes or as Fgf8Δ2,3/Fgf8Δ2,3n compound heterozygotes appeared similar at all stages examined. The data on embryos of these genotypes, hereafter referred to as Fgf8−/− or mutant embryos, were therefore pooled. Such embryos could be recognized as early as E7.0 (mid-streak stage) by an abnormal thickening on the posterior side (data not shown). At ~E7.5, when their wild-type or mutant heterozygous littermates (hereafter referred to as Fgf8+ or normal embryos) were at the late-streak/neural plate stage, the mutant embryos were found to be abnormally narrow, with an indentation on the posterior side and a mass of cells in the proamniotic cavity (Fig. (Fig.1A).1
Normally, as the streak elongates, the cell population that was initially localized in the distal epiblast is displaced proximally and expands into the area occupied previously by cells that entered the streak (Lawson et al. 1991; Quinlan et al. 1995). In mutant embryos at ~E7.5, the streak appeared to be relatively normal in overall length, particularly when distortions resulting from the failure of mesoderm migration were taken into account (Fig. (Fig.1G,H).1
Visual inspection of sagittal sections suggested that despite their morphogenetic abnormalities, mutant embryos contain approximately the same total number of cells as their normal littermates. To investigate this point, we collected a litter of eight conceptuses at ~E7.75, disaggregated them individually, and counted the total number of cells (embryonic and extraembryonic) in each one. The three that were identified as mutant by morphological criteria contained 45,900 ± 1011 cells. Their five morphologically normal littermates contained 50,020 ± 2274 cells. Using Student’s t-test, these numbers are not statistically different. These data suggest that loss of Fgf8 function has little effect on cell proliferation and/or survival during the primitive streak stages of development.As the mutant embryos developed beyond the streak stages, we observed expansion of the amniotic cavity and elongation along the A-P axis, with the bulging primitive streak region remaining at the caudal end of the embryo (Fig. (Fig.1I–L).1 Development of the extraembryonic region in Fgf8−/− embryosAlthough the extraembryonic region is histologically abnormal, the morphogenetic processes that result in the formation of the extraembryonic tissues occur in Fgf8−/− embryos. In the normal embryo, cells that traverse the proximal portion of the primitive streak move into the extraembryonic region (Lawson et al. 1991). Subsequently, lacunae form within the extraembryonic mesodermal cell population, particularly on the posterior side, gradually expand, and coalesce to form the exocoelom (asterisk in Fig. Fig.1E).1 In the normal conceptus, a population of extraembryonic mesoderm cells localized on the posterior side develops into the allantois, which grows across the exocoelom and eventually fuses with the chorion to become part of the placenta. In the mutants an allantois was present and usually relatively normal in size, but it was often displaced anteriorly (Fig. (Fig.1J,L).1 Analysis of gene expression in cells traversing the primitive streakThe observations described above demonstrate that cells move into the primitive streak and undergo an EMT in Fgf8−/− embryos and that cells traversing the proximal primitive streak differentiate into the normal complement of extraembryonic cell types. To investigate the development of the streak region further, we performed an in situ hybridization analysis using probes for genes that are normally expressed throughout the streak and in its embryonic derivatives. In the normal embryo beginning at ~E6.5, expression of the T gene specifically marks all cells in the primitive streak. At E7.75 and later stages, it also marks the axial mesoderm cell population that extends rostrally from the anterior (distal) end of the primitive streak (Fig. (Fig.2A,C,E;2 We next assayed for Lim1 RNA, which is normally detected in midstreak-stage embryos at low levels in cells in the primitive streak and at much higher levels in mesodermal cells migrating away from the streak. It is also detected in the VE on the anterior side of the embryo (anterior VE, AVE) as well as in mesendoderm migrating rostrally from the anterior end of the streak (Fig. (Fig.2I,K;2 Regionalization of the primitive streak in Fgf8−/− embryos In the normal embryo, the primitive streak is regionalized with respect to cell fate: Cells that traverse the proximal-most (posterior) end of the streak become extraembryonic mesoderm, whereas those that traverse the distal-most (anterior) end become axial mesoderm and definitive endoderm (mesendoderm) (Lawson et al. 1991). Our finding that extraembryonic mesoderm derivatives such as allantois, blood, and endothelial cells are formed in Fgf8−/− embryos indicates that regionalization of the proximal end of the streak is relatively normal in the absence of FGF8. Consistent with this conclusion, Bmp4 expression, which is detected in the amnion, allantois, and posterior streak of the wild-type embryo (Winnier et al. 1995), appeared normal in the mutants (data not shown). To determine whether the anterior end of the streak is regionalized we assayed for the expression of several genes. In normal embryos at ~E7, Goosecoid (Gsc) and Hnf3β RNAs are detected in cells at the anterior end of the primitive streak and their derivatives, as well as in the AVE, although the latter expression domain is sometimes difficult to detect (Fig. (Fig.3A,C;3 We also examined the pattern of expression of Nodal (Ndl) in Fgf8−/− embryos heterozygous for NdllacZ, an allele in which lacZ disrupts the Nodal gene and functions as a reporter for Ndl expression (Collignon et al. 1996). At all stages examined, Fgf8−/−;NdllacZ/+ embryos were indistinguishable from their Fgf8−/−;Ndl+/+ littermates, indicating that a decrease in Ndl expression does not increase the severity of the Fgf8−/− mutant phenotype. In the normal early embryo Ndl expression is very dynamic and involves a step-wise restriction of the expression domain, which is initially widespread in the epiblast at E6.5 and then localized around the node by E8.0 (Fig. (Fig.3J,L,N;3 Anterior neuroectodermal markers are expressed but not regionally restricted in Fgf8−/− embryosWe next sought to determine how loss of Fgf8 function affected the development of the anterior side of the embryo. We first assayed for expression of Hex, a gene that marks the AVE beginning at the prestreak stage, when this cell population is located at the distal tip of the embryo. Hex expression continues in the AVE as it moves proximally, spreading along the P-D length of the anterior side of the embryo (Thomas et al. 1998). As the definitive endoderm is formed and moves rostrally from the distal end of the streak and node, it displaces most of the VE, including the AVE, proximally into the extraembryonic region (Lawson et al. 1991; Thomas and Beddington 1996). Because Hex expression also marks the definitive endoderm population, it continues to be detected on the anterior side of the embryo. However, the Hex expression domain becomes progressively more restricted and by ~E7.5 is normally detected in a small group of definitive endoderm cells just distal to the em/ex border (Fig. (Fig.4A;4
Hesx1 (also known as Rpx; Hermesz et al. 1996; Thomas and Beddington 1996) is another gene that is initially expressed in the AVE and subsequently in the definitive endoderm. Beginning at the late-streak stage, Hesx1 expression is induced in the prospective neuroectoderm overlying the Hesx1-positive domain in the endoderm near the em/ex border. Hesx1 expression subsequently intensifies and spreads laterally in the neuroectoderm but remains restricted to the most anterior portion of the developing brain until ~E9.5 (Fig. (Fig.4C;4 Otx2 is another gene whose expression is normally detected in the anterior neuroectoderm at the late-streak stage, in the region encompassing the prospective forebrain and midbrain (Fig. (Fig.4G;4 We also assayed for Gbx2, a gene required for patterning the anterior hindbrain (Wassarman et al. 1997). It is normally expressed in all three germ layers at the late-streak/neural plate stage, in a domain that extends caudally from the prospective midbrain/hindbrain boundary through the primitive streak to the posterior end of the embryo (Fig. (Fig.4I;4 FGF8 is required for expression of Fgf4 in the primitive streakPrevious studies have shown that Fgf3 expression, which is normally detected transiently in embryonic mesodermal cells exiting the primitive streak and in the extraembryonic mesoderm (Fig. (Fig.5A,C,E;5
Discussion During mouse gastrulation, Fgf8 and Fgf4 are coexpressed in the primitive streak: Fgf4 is highly expressed at the distal end and barely detectable at the proximal end, whereas Fgf8 is expressed in an opposite gradient throughout the streak. Surprisingly, Fgf4 is not expressed in the streak of Fgf8−/− embryos. Presumably it is expressed prior to E6.5, otherwise Fgf8 mutants would die at the time of implantation, as Fgf4−/− embryos do (Feldman et al. 1995). Thus, elimination of Fgf8 function in effect mimics a primitive streak-specific knock-out of Fgf4, making possible an analysis of the combined function of FGF8 and FGF4 (FGF8/4) in the primitive streak. The most striking feature of this double loss-of-function phenotype is a massive accumulation of cells on the posterior side of the embryo, which results from the failure of most cells that have entered the streak and appear to have made the EMT to migrate away from the streak region. Consequently, the embryonic portion of the conceptus develops in the almost complete absence of mesoderm- and definitive endoderm-derived tissues. In turn, this greatly perturbs the patterning of the prospective neuroectoderm. FGF signaling is required for cell migration away from the primitive streakThe primary defect in Fgf8 mutant embryos is a failure of cell movement away from the streak. Although there is virtually no development of embryonic tissues, the extraembryonic region apparently contains all the structures and cell types normally found there: The amnion and chorion are formed, the allantois develops, and hematopoietic, endothelial, and presumptive germ cells are detected, but they are present in smaller numbers than normal and are abnormally localized. Thus, the prospective extraembryonic cells, which traverse the proximal portion of the streak, are able to exit it and move proximally into the extraembryonic region, whereas most prospective embryonic mesoderm and endoderm cells, which traverse more distal regions, are unable to exit the streak. One possible explanation for this difference is that there is regional variation in the mechanism by which cells move away from the streak. Time-lapse micrography of gastrulating mouse embryos has shown that migration away from the distal region of the streak is an active process (Nakatsuji et al. 1986). Our data demonstrate that some aspect of this active process is dependent on FGF8- and/or FGF4-mediated signal transduction. The fact that a small fraction of cells can move away from the streak in Fgf8−/− embryos may reflect functional redundancy between FGF8/4 and FGF17, which is also produced in the streak (Maruoka et al. 1998), or some other FGF family member that has yet to be identified. In contrast, cell movement into the extraembryonic region may be a more passive process that does not require FGF signaling, and once there, cells may be displaced to the anterior side without active migration. For example, the cells lining the wall of the exocoelom are apparently spread anteriorly in the normal conceptus by a process involving expansion of the fluid-filled exocoelomic cavity in which both the extraembryonic mesoderm and ectoderm cells are thinned and stretched. Such a process, which does not appear to require active cell movement, could account for the presence of mesoderm on the anterior side of the extraembryonic region in Fgf8 mutant embryos. On the other hand, the observation that blood and endothelial cells are localized exclusively on the posterior side (Fig. (Fig.1,1 An important question is whether the mutant phenotype described here is due to the absence of FGF8, FGF4, or both. Studies of embryos homozygous for a null allele of eed, a gene homologous to Drosophila extra sex combs (Schumacher et al. 1996), suggest that FGF4 is required for cell migration away from the streak. In eed mutant embryos, Fgf4 is not expressed in the primitive streak (Faust et al. 1995), but Fgf8 expression appears to be normal (T. Magnuson, pers. comm.). An elegant lineage analysis has demonstrated that loss of eed function causes epiblast cells to preferentially make mesoderm, which is then unable to migrate anteriorly and laterally away from the primitive streak and becomes mislocalized to the extraembryonic region (Faust et al. 1998). It is tempting to speculate that the migration defects in the eed mutant embryos are due to the absence of FGF4, thus accounting for the many similarities in the eed and Fgf8 mutant phenotypes. Features that are specific to the eed mutants, including excess extraembryonic mesoderm and failure of the primitive streak to elongate normally, are presumably caused by loss of eed function per se. A test of the hypothesis that FGF4 is required for cell migration from the primitive streak will require streak-specific inactivation of Fgf4 to circumvent the early lethality of Fgf4−/− embryos. Because the absence of FGF4 does not affect Fgf8 expression, at least in eed mutant embryos, it should be possible to determine the specific function of Fgf4 by inactivating it in the streak. Mesodermal cells also accumulate in the streak region of Fgfr1−/− embryos (Deng et al. 1995; Yamaguchi et al. 1995), suggesting that the Fgf8/4 signal required for cell migration is transduced by FGFR1. However, the Fgfr1 mutant phenotype is less severe than that of Fgf8−/− embryos: More cells migrate away from the streak region and thus there is substantially more development of mesoderm- and endoderm-derived tissues in many of the Fgfr1−/− embryos. This raises the possbility that loss of Fgfr1 function only partially inhibits FGF signaling via FGF8/4 and that another FGF receptor functions in conjunction with FGFR1 during gastrulation. Additional expression and genetic analysis will need to be carried out to test this hypothesis. Other functions of FGF signaling during gastrulationStudies on Xenopus animal caps have suggested that FGF signaling plays a role in mesoderm induction (Kimelman and Kirschner 1987; Slack et al. 1987). However, interference with FGFR function in Xenopus embryos (Amaya et al. 1991) and loss of Fgfr1 function in the mouse (Deng et al. 1995; Yamaguchi et al. 1995) have no obvious effect on the initiation of gastrulation. Although the Fgf8 mutant embryos display some morphological abnormalities suggestive of a slower than normal rate of cell entry into the streak, it seems likely that such defects are a secondary consequence of the ‘traffic jam’ in the streak. Two lines of evidence suggest that FGF signaling may play a role in the EMT at gastrulation: Treatment of mouse anterior epiblast explants with FGF2 causes them to undergo an EMT (Burdsal et al. 1993), and mutant cells accumulate in the epithelial portion of the streak in Fgfr1−/− ↔ Fgfr+/+ chimeras. This led Ciruna et al. (1997) to suggest that the primary defect associated with loss of FGFR1 function is a deficiency in the ability to make the EMT. Although the epiblast is deformed in the streak region of Fgf8 mutant embryos, this does not seem to be because of an excess of epithelial cells, but rather because of the accumulation of cells that have completed the EMT but are then unable to migrate away from the streak region (see Fig. Fig.1C,D).1There is also some evidence that FGF signaling may be required for the specification of mesodermal cell fate. Analysis of marker gene expression in developmentally advanced Fgfr1−/− embryos showed a remarkable excess of axial mesoderm and a paucity of paraxial mesoderm (Yamaguchi et al. 1995). It has been suggested that this phenotype is secondary to reduced cell movement through the streak (Ciruna et al. 1997). However, we found that primitive streak cells in Fgf8 mutant embryos fail to express Tbx6, a gene required for the specification of posterior paraxial mesoderm (Chapman and Papaioannou 1998). This raises the possibility that in addition to effects on cell migration, FGF8/4 signaling, perhaps via FGFR1, has a role in regulating the expression of genes involved in cell fate determination. Fgfr1−/− embryos were reported to be significantly smaller than their normal littermates, and the outgrowths of Fgfr1−/− embryos in vitro were consistently smaller than those formed by normal embryos (Deng et al. 1995; Yamaguchi et al. 1995), suggesting that FGFR1 signaling may stimulate cell proliferation or survival in the gastrulating embryo. On the other hand, when Fgfr1−/− or Fgfr1−/+ embryonic stem (ES) cells were combined with wild-type embryos, the ES cells of the two genotypes made similar contributions to the resulting chimeric embryos, arguing against a role for FGFR1 in cell proliferation or survival (Ciruna et al. 1997). Our data suggest that signaling via FGF8/4 is not required for these processes, although we cannot rule out the possibility that the proliferation rate in specific regions of the embryo, such as the streak itself, is abnormal in Fgf8−/− embryos. How does FGF signaling control cell migration? In invertebrates, FGF signaling is also necessary for cell migration. For example, in Drosophila it is required for migration and spreading of the embryonic mesoderm over the ectoderm and for branching morphogenesis of the tracheal system, and in Caenorhabditis elegans it is required for sex myoblast migration. In both organisms, ectopic expression experiments have suggested that FGFs can function as attractants for cell migration (for review, see Skaer 1997; Chen and Stern 1998). By analogy, one might argue that FGF8 produced in the VE acts as an attractant for cell migration away from the streak. We tested this hypothesis by injecting wild-type embryonic stem cells into Fgf8−/− blastocysts, producing chimeras in which the VE presumably contained only Fgf8−/− cells, whereas the epiblast contained a mixture of wild-type and mutant cells. No defects in gastrulation were detected in four such chimeras, in which at least 25% of the embryonic cell population was derived from wild-type ES cells. In these embryos, Fgf8−/− cells contributed to all tissues, including somites, head mesenchyme, and foregut (data not shown). These results indicate that lack of FGF8 in the VE is not responsible for the gastrulation defects in Fgf8 mutant embryos. Instead, FGF signaling appears to be required in the primitive streak itself, presumably to regulate the production of proteins necessary for cell migration. Genes that encode molecules involved in adhesive interactions between cells and their surrounding extracellular matrix (ECM) are obvious candidates for the downstream targets affected by loss of Fgf8 function. Mutational analysis has shown that there is a deficit of mesoderm in embryos homozygous for null alleles of Fibronectin (George et al. 1993), Integrin α5 (Yang et al. 1993), and Focal adhesion kinase (Furuta et al. 1995), which encode a component of the ECM, part of the receptor for Fibronectin, and a nonreceptor tyrosine kinase thought to mediate Integrin signaling, respectively. This suggests that those genes might be required for cell migration away from the primitive streak. However, abnormalities in the mutant embryos are not detected until at least the late headfold stage. It therefore seems unlikely that the more severe phenotype of Fgf8−/− embryos is due to effects of FGF8/4 signaling on any one of these genes, although it remains possible that the defects are due to simultaneous effects on more than one such gene. Another type of molecule that appears to play some role in cell migration away from the primitive streak is the transcription factor T. When the behavior of T null homozygous cells is monitored in chimeras, they are found to accumulate in the mesodermal layer of the streak region, but this effect is not evident until the headfold stage (Wilson et al. 1995). Moreover, T null mutant embryos do not show any obvious defects at the primitive streak stages (Chesley 1935). The fact that Fgf8 mutant embryos display a more severe phenotype argues against interference with T expression as the primary cause of the defect in cell migration. However, other genes related to T might be the downstream targets of FGF signaling required for cell migration away from the streak. Consistent with this hypothesis, we have found that FGF8/4 signaling regulates expression of at least some T-related genes. For example, Tbx6 is not expressed in Fgf8−/− embryos. Furthermore, although T expression is detected in epithelial cells in the mutant streak region, it is not detected in nascent mesenchymal cells that have traversed the streak and accumulated there (Fig. (Fig.2D,F).2 Patterning defects in the prospective neuroectoderm In Fgf8 mutant embryos, there is widespread expression throughout the anterior ectoderm of genes whose expression domains are normally restricted within the prospective anterior neuroectoderm, as well as a lack of expression of genes that normally mark the prospective hindbrain. These abnormalities arise from the failure of different aspects of the neuroectoderm patterning process. One source of signals that pattern the prospective neuroectoderm is the AVE (Beddington and Robertson 1998, 1999). Precursors of the AVE are initially localized in the VE at the distal tip of the embryo, but just prior to streak formation they become distributed along the future anterior midline and are later displaced proximally into the extraembryonic region by definitive endoderm migrating anteriorly from the anterior streak. When AVE progenitors remain distal, as in embryos homozygous for a null allele of Cripto, gene expression normally restricted to the anterior neuroectoderm is detected throughout the distal ectoderm (Ding et al. 1998). In Fgf8 mutant embryos, expression of Lim1 and Hex, two markers of the AVE, persists along the anterior midline of the mutant embryos (Figs. (Figs.2J2 Mesoderm and definitive endoderm are also a source of neuroectoderm patterning signals (for review, see Doniach 1993; Ruiz i Altaba 1993). For example, explant-recombination experiments have shown that streak-derived tissue from the posterior side produces signals that can repress Otx2 expression and that anterior mesendoderm produces signals that can induce and maintain Otx2 expression. Together, these signals appear to be responsible for the progressive restriction of the Otx2 expression domain to the forebrain and midbrain (Ang et al. 1994). In Fgf8−/− embryos, Otx2 expression was detected throughout the anterior ectoderm. This failure to become restricted within the anterior ectoderm is most likely due to the absence of streak-derived tissue underlying the prospective neuroectoderm resulting from the lack of cell migration away from the streak. The lack of mesoderm, which is thought to be a potent source of vertical signals that pattern the prospective hindbrain and spinal cord, is also likely to explain the lack of expression of posterior neuroectoderm markers such as Hoxb1 and Gbx2. It is also possible that the absence of a normal node, from which planar signals to the neuroectoderm are thought to emanate, contributes to the abnormalities detected in the anterior ectoderm of Fgf8 mutant embryos. Conclusion The data reported here identify FGF8 as a factor required for cells that have undergone the EMT to move away from the streak, possibly because it is necessary for expression of Fgf4. However, in other developmental settings in the vertebrate embryo these same ligands appear to play a role in controlling cell proliferation, cell survival, and embryonic patterning. One of the major challenges for the future will be to understand what determines the specific downstream responses to signaling by a particular FGF ligand and how that leads to a specific biological response such as cell migration. Materials and methods Production and analysis of mutant embryos The Fgf8Δ2,3 and Fgf8Δ2,3n alleles (Meyers et al. 1998) were maintained on a mixed genetic background. Mutant homozygotes were obtained from appropriate crosses of heterozygous mice. They were identified either by their characteristic morphology or by PCR analysis. PCR amplification of DNA fragments unique to Fgf8Δ2,3 or Fgf8Δ2,3n was performed using the primer pairs 5′-CTTAGGGCTATCCAACCCATC-3′ and 5′-AGCTCCCGCTGGATTCCTC-3′ or 5′-GTTCTAAGTACTGTGGTTTCC-3′ and 5′-AGCTCCCGCTGGATTCCTC-3′, respectively. Standard protocols were used, with an annealing temperature of 54°C. Normal embryos used for comparison were either mutant heterozygous or wild-type littermates of the Fgf8 mutant homozygotes or were stage-matched wild-type embryos obtained from crosses of outbred mice. Noon of the day on which the vaginal plug was detected was considered as E0.5 in the timing of embryo collection. All dissections were performed in phosphate buffered saline (PBS) and embryos were fixed overnight in 4% paraformaldehyde (PFA) at 4°C. Samples for histological analysis were embedded in plastic resin (JB-4 catalyzed resin, Polysciences, Inc., Warrington, PA.) according to the manufacturer’s protocol. Sections were cut at 5 μm and stained with hematoxylin and eosin. Samples for scanning electron microscopy were prepared according to standard protocols; the embryos were bisected after fixation but prior to dehydration. Cell number in individual embryos was determined using a hemacytometer. The embryos were disaggregated by incubating them in 0.05% trypsin for 20 min at 37°C. Whole-mount RNA in situ hybridization analysis was carried out as described previously (Neubüser et al. 1997) using riboprobes prepared from plasmids described in references cited for each gene. For sectioning after staining, the embryos were postfixed in 4% PFA with 0.1% glutaraldehyde and embedded in plastic resin as described above. Sections were counterstained with 0.1% nuclear fast red. Ndl expression was analyzed by staining for β-gal activity in embryos carrying the NdllacZ allele (Collignon et al. 1996). Fgf8Δ2,3n /+;NdllacZ/+ double heterozygotes are normal and fertile. They were crossed to Fgf8Δ2,3n /+ mice to generate Fgf8−/−; NdllacZ/+ embryos. Acknowledgments We thank S.-L. Ang, R. Beddington, R. Behringer, E. De Robertis, P. Gruss, B. Herrmann, A. McMahon, K. Mahon, S. Orkin, V. Papaioannou, and J. Rossant for providing the probes and E. Robertson for providing the NdllacZ mice used in this study. We are grateful to M. Flannery and R. Pederson for providing the wild-type embryo sections shown in Figure Figure1E,G;1 The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked ‘advertisement’ in accordance with 18 USC section 1734 solely to indicate this fact. Footnotes E-MAIL gmartin/at/itsa.ucsf.edu; FAX (415) 476-3493. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Mech Dev. 1997 Nov; 68(1-2):3-25.
[Mech Dev. 1997]Cell. 1987 Dec 4; 51(5):869-77.
[Cell. 1987]Nature. 1987 Mar 12-18; 326(6109):197-200.
[Nature. 1987]Biochem Soc Symp. 1996; 62():1-12.
[Biochem Soc Symp. 1996]Development. 1997 Jul; 124(14):2829-41.
[Development. 1997]J Biol Chem. 1998 Jul 17; 273(29):18161-4.
[J Biol Chem. 1998]EMBO J. 1988 Mar; 7(3):691-5.
[EMBO J. 1988]Development. 1992 Mar; 114(3):755-68.
[Development. 1992]Development. 1991 Jun; 112(2):397-406.
[Development. 1991]Development. 1991 Jun; 112(2):407-15.
[Development. 1991]Development. 1995 Feb; 121(2):439-51.
[Development. 1995]Curr Biol. 1995 Jul 1; 5(7):797-806.
[Curr Biol. 1995]Mech Dev. 1998 Jun; 74(1-2):175-7.
[Mech Dev. 1998]Nat Genet. 1998 Feb; 18(2):136-41.
[Nat Genet. 1998]Adv Cancer Res. 1992; 59():115-65.
[Adv Cancer Res. 1992]Development. 1991 Nov; 113(3):891-911.
[Development. 1991]Development. 1995 Jan; 121(1):87-98.
[Development. 1995]Development. 1991 Nov; 113(3):891-911.
[Development. 1991]Development. 1990 Oct; 110(2):521-8.
[Development. 1990]Cell. 1997 Jul 11; 90(1):109-19.
[Cell. 1997]Development. 1994 Sep; 120(9):2539-53.
[Development. 1994]Nature. 1990 Feb 15; 343(6259):657-9.
[Nature. 1990]Dev Biol. 1992 May; 151(1):273-87.
[Dev Biol. 1992]Dev Biol. 1996 Dec 15; 180(2):534-42.
[Dev Biol. 1996]Nature. 1995 Mar 30; 374(6521):425-30.
[Nature. 1995]Mech Dev. 1997 Nov; 68(1-2):45-57.
[Mech Dev. 1997]Dev Biol. 1994 Jan; 161(1):168-78.
[Dev Biol. 1994]Development. 1991 Nov; 113(3):891-911.
[Development. 1991]Genes Dev. 1995 Sep 1; 9(17):2105-16.
[Genes Dev. 1995]Cell. 1992 Jun 26; 69(7):1097-106.
[Cell. 1992]Development. 1993 Dec; 119(4):1301-15.
[Development. 1993]Development. 1993 May; 118(1):47-59.
[Development. 1993]Nature. 1996 May 9; 381(6578):155-8.
[Nature. 1996]Development. 1997 Mar; 124(5):1033-44.
[Development. 1997]Development. 1998 Jan; 125(1):85-94.
[Development. 1998]Development. 1991 Nov; 113(3):891-911.
[Development. 1991]Curr Biol. 1996 Nov 1; 6(11):1487-96.
[Curr Biol. 1996]Development. 1996 Jan; 122(1):41-52.
[Development. 1996]Curr Biol. 1996 Nov 1; 6(11):1487-96.
[Curr Biol. 1996]Development. 1995 Dec; 121(12):4045-55.
[Development. 1995]EMBO J. 1993 Jul; 12(7):2735-47.
[EMBO J. 1993]Development. 1994 Oct; 120(10):2979-89.
[Development. 1994]Development. 1997 Aug; 124(15):2923-34.
[Development. 1997]Dev Dyn. 1995 Dec; 204(4):372-82.
[Dev Dyn. 1995]Development. 1990 Oct; 110(2):589-607.
[Development. 1990]EMBO J. 1988 Mar; 7(3):691-5.
[EMBO J. 1988]Development. 1992 Mar; 114(3):755-68.
[Development. 1992]Development. 1991 Jun; 112(2):397-406.
[Development. 1991]Development. 1991 Jun; 112(2):407-15.
[Development. 1991]Science. 1995 Jan 13; 267(5195):246-9.
[Science. 1995]J Embryol Exp Morphol. 1986 Jul; 96():99-109.
[J Embryol Exp Morphol. 1986]Mech Dev. 1998 Jun; 74(1-2):175-7.
[Mech Dev. 1998]Development. 1995 Feb; 121(2):273-85.
[Development. 1995]Development. 1998 Nov; 125(22):4495-506.
[Development. 1998]Cell. 1987 Dec 4; 51(5):869-77.
[Cell. 1987]Nature. 1987 Mar 12-18; 326(6109):197-200.
[Nature. 1987]Cell. 1991 Jul 26; 66(2):257-70.
[Cell. 1991]Development. 1993 Jul; 118(3):829-44.
[Development. 1993]Development. 1997 Jul; 124(14):2829-41.
[Development. 1997]Development. 1997 Jul; 124(14):2829-41.
[Development. 1997]Nature. 1998 Feb 12; 391(6668):695-7.
[Nature. 1998]Development. 1997 Jul; 124(14):2829-41.
[Development. 1997]Trends Genet. 1998 Aug; 14(8):322-7.
[Trends Genet. 1998]Development. 1993 Dec; 119(4):1079-91.
[Development. 1993]Development. 1993 Dec; 119(4):1093-105.
[Development. 1993]Oncogene. 1995 Nov 16; 11(10):1989-95.
[Oncogene. 1995]Development. 1995 Mar; 121(3):877-86.
[Development. 1995]Cold Spring Harb Symp Quant Biol. 1997; 62():337-46.
[Cold Spring Harb Symp Quant Biol. 1997]Development. 1998 Sep; 125(17):3379-88.
[Development. 1998]Trends Genet. 1998 Jul; 14(7):277-84.
[Trends Genet. 1998]Cell. 1999 Jan 22; 96(2):195-209.
[Cell. 1999]Nature. 1998 Oct 15; 395(6703):702-7.
[Nature. 1998]J Neurobiol. 1993 Oct; 24(10):1256-75.
[J Neurobiol. 1993]J Neurobiol. 1993 Oct; 24(10):1276-304.
[J Neurobiol. 1993]Development. 1994 Oct; 120(10):2979-89.
[Development. 1994]Nat Genet. 1998 Feb; 18(2):136-41.
[Nat Genet. 1998]Cell. 1997 Jul 25; 90(2):247-55.
[Cell. 1997]Nature. 1996 May 9; 381(6578):155-8.
[Nature. 1996]